This website is intended for Healthcare Professionals outside of the UK and the US.

Sometimes, purpura fulminans
can hide SCPCD.

Even if the most frequent cause of purpura fulminans in neonates is sepsis, Severe Congenital Protein C Deficiency (SCPCD) can also lead to this disorder, with lesions appearing as early as 2-12 hours after birth.1,2 A timely protein C test can help physicians diagnose and manage this rare condition, allowing rapid management that can reduce morbidity and save the lives of infants.2,3

What is SCPCD?

Severe Congenital Protein C Deficiency is an autosomal recessive, rare disorder that leads to high initial mortality and long-term morbidity in survivors1,3. In neonates, SCPCD can manifest, as early as 2-12 hours after birth, as purpura fulminans with necrosis of the skin, disseminated intravascular coagulation, arterial and venous thrombosis.2-4

Read more
Differential Diagnosis Desktop 400X240

Differential Diagnosis

Purpura fulminans:
Is it sepsis or SCPCD?

Scpcd7

SCPCD action tool

Suggested actions if you’re facing purpura fulminans and must determine whether it's due to sepsis or SCPCD.

Which Scpdp Desktop 835X470

Which
tests confirm
SCPCD?

There are several recommended tests that can help you determine whether your patient has SCPCD.

How Scpdp Desktop 835X470 2

Options for management
of SCPCD

Treating acute manifestations of SCPCD include protein C replacement, anti-coagulation and liver transplantation.5

References:

  1. Chalmers E, et al. Purpura fulminans: recognition, diagnosis and management. Archives of Disease in Childhood. 2011;96(11):1066-1071.

  2. Price VE, et al. Diagnosis and management of neonatal purpura fulminans. Semin Fetal Neonatal Med. 2011;16(6):318-22.

  3. Goldenberg N, Manco-Johnson M. Protein C deficiency. Haemophilia. 2008;14(6):1214–1221.

  4. Marlar RA, et al. Report on the diagnosis and treatment of homozygous protein C deficiency. Report of the Working Party on Homozygous Protein C Deficiency of the ICTH-Subcommittee on Protein C and Protein S. Thromb Haemost. 1989;61(3):529-31.

  5. Kroiss S, Albisetti M. Use of human protein C concentrates in the treatment of patients with severe congenital protein C deficiency. Biologics: Targets & Therapy. 2010;4:51–60.

Interested in Severe Congenital Protein C Deficiency (SCPCD) and its management?
Sign up below!

Sorry! There are some errors below that need to be fixed.
There seems to have been an error when sending the form.

You have the right to opt out of receiving such electronic communications at any time by using the opt out link in the communication you will receive or by contacting us at privacyconnect@shire.com. For more information on how Shire processes your personal data, please refer to our Privacy Notice.

Please include @ in your email adress
*Required
Register

Thanks

Thank you for submitting your details

You are about to leave this website. Shire has no influence or control over the content of this third party website.
Continue Cancel
WELCOME TO SCPCD.org
This site is intended for healthcare professionals outside of the US and UK. Please verify that you are a healthcare professional by checking one of the boxes below :
Please tick the boxes to enter the site

Yes, I am a healthcare professional outside of the US and UK

YES

No, I am not a healthcare professional outside of the US and UK

NO